COYA
Coya Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
COYA Filings
Filing Date
Form Description
Form Type
2025-11-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-10-27
Form 8-K - Current report
Key Events
2025-10-27 · Key Events
Form 8-K - Current report
2025-10-27
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-10-27 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-10-23
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-10-23 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-09-02
Form 8-K - Current report
Key Events
2025-09-02 · Key Events
Form 8-K - Current report
2025-08-20
Form EFFECT - Notice of Effectiveness
2025-08-20 ·
Form EFFECT - Notice of Effectiveness
2025-08-19
Form 424B7 - Prospectus [Rule 424(b)(7)]
2025-08-19 ·
Form 424B7 - Prospectus [Rule 424(b)(7)]
2025-08-19
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-08-19 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-08-18
Form CORRESP - Correspondence
SEC Inquiries
2025-08-18 · SEC Inquiries
Form CORRESP - Correspondence
